Last update 01 Nov 2024

Japan Dapeng Pharmaceutical Industry Co., Ltd. Beijing Representative Office

Private Company|
2006|
Beijing Shi, China

Overview

Tags

Endocrinology and Metabolic Disease
Respiratory Diseases
Digestive System Disorders
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
TYMS(Thymidylate synthase)1

Related

1
Drugs associated with Japan Dapeng Pharmaceutical Industry Co., Ltd. Beijing Representative Office
Tegafur/Gimeracil/Oteracil Potassium
Target
TYMS
Mechanism
TYMS inhibitors
Active Org.
Sawai Pharmaceutical Co., Ltd.Sawai Pharmaceutical Co., Ltd. [+6]
Originator Org.
Taiho Pharmaceutical Co., Ltd.Taiho Pharmaceutical Co., Ltd.
Active Indication
Hormone receptor positive HER2 negative breast cancer [+11]
Inactive Indication
Advanced cancer [+15]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date04 Apr 2001
3
Clinical Trials associated with Japan Dapeng Pharmaceutical Industry Co., Ltd. Beijing Representative Office
CTR20130059 / Active, not recruitingPhase 3
比较S-1与多西他赛治疗既往接受过以铂类为基础的化疗方案治疗的非小细胞肺癌受试者的随机对照临床试验。
[Translation] A randomized controlled clinical trial comparing S-1 with docetaxel in subjects with non-small cell lung cancer who have received prior platinum-based chemotherapy.
CTR20130062 / CompletedPhase 3
以多西他赛/顺铂联合化疗为对照、验证替吉奥胶囊/顺铂联合化疗治疗晚期肺癌初治患者的疗效和安全性。
[Translation] Using docetaxel/cisplatin combination chemotherapy as a control, the efficacy and safety of S-100 capsule/cisplatin combination chemotherapy in the treatment of first-line patients with advanced lung cancer were verified.
CTR20130061 / CompletedPhase 3
以吉西他滨为对照评价替吉奥胶囊单药一线治疗晚期胰腺癌的疗效和安全性的多中心随机开放平行对照研究。
[Translation] A multicenter, randomized, open, parallel controlled study using gemcitabine as a control to evaluate the efficacy and safety of S-1 capsules as a first-line treatment for advanced pancreatic cancer.
100 Clinical Results associated with Japan Dapeng Pharmaceutical Industry Co., Ltd. Beijing Representative Office
Login to view more data
0 Patents (Medical) associated with Japan Dapeng Pharmaceutical Industry Co., Ltd. Beijing Representative Office
Login to view more data
100 Deals associated with Japan Dapeng Pharmaceutical Industry Co., Ltd. Beijing Representative Office
Login to view more data
100 Translational Medicine associated with Japan Dapeng Pharmaceutical Industry Co., Ltd. Beijing Representative Office
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Tegafur/Gimeracil/Oteracil Potassium
 ( TYMS )		Non-Small Cell Lung Cancer
More
Phase 3
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free